Filters: keyword is Analgesics [Clear All Filters]
- 2008
Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics,
Eur J Pharm Sci, vol. 34, no. 2-3, pp. 149-63.
Prediction of attack frequency in migraine treatment,
Cephalalgia, vol. 28, no. 8, pp. 847-55.
- 2007
Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEG,
Br J Pharmacol, vol. 151, no. 5, pp. 713-20.
Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux,
Br J Pharmacol, vol. 151, no. 5, pp. 701-12.
Application of the convection-dispersion equation to modelling oral drug absorption,
Bull Math Biol, vol. 69, no. 1, pp. 181-95.
Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers,
Clin Pharmacol Ther, vol. 81, no. 1, pp. 50-8.
Animal-to-human extrapolation of the pharmacokinetic and pharmacodynamic properties of buprenorphine,
Clin Pharmacokinet, vol. 46, no. 5, pp. 433-47.
Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers,
Clin Pharmacokinet, vol. 46, no. 11, pp. 965-80.
- 2006
Buprenorphine induces ceiling in respiratory depression but not in analgesia,
Br J Anaesth, vol. 96, no. 5, pp. 627-32.
Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers,
Anesthesiology, vol. 104, no. 6, pp. 1232-42.
- 2005
Pharmacokinetic/pharmacodynamic modelling of the anti-hyperalgesic and anti-nociceptive effect of adenosine A1 receptor partial agonists in neuropathic pain,
Eur J Pharmacol, vol. 514, no. 2-3, pp. 131-40.
Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats,
Br J Anaesth, vol. 94, no. 6, pp. 825-34.
Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics,
J Pharmacol Exp Ther, vol. 313, no. 3, pp. 1136-49.
- 2004
Population pharmacokinetic-pharmacodynamic modelling of the anti-hyperalgesic effect of 5'deoxy-N6-cylopentyladenosine in the mononeuropathic rat,
Eur J Pharmacol, vol. 504, no. 1-2, pp. 7-15.
- 2000
- 1999
The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model,
Anesthesiology, vol. 90, no. 2, pp. 535-44.
- 1998
Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor,
J Pharmacol Exp Ther, vol. 284, no. 3, pp. 1095-103.
Pharmacokinetic-pharmacodynamic modelling of the analgesic effect of alfentanil in the rat using tooth pulp evoked potentials,
J Pharmacol Toxicol Methods, vol. 39, no. 1, pp. 19-27.
Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation,
Br J Pharmacol, vol. 124, no. 7, pp. 1534-40.
- 1997
Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats,
J Pharmacol Toxicol Methods, vol. 38, no. 2, pp. 99-108.
- 1995
Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain,
Br J Pharmacol, vol. 116, no. 5, pp. 2538-44.



